object
evalu
vitro
activ
ethyl
acet
ea
fraction
houttuynia
cordata
h
cordata
thunb
saururacea
three
constitu
flavonoid
quercetin
quercitrin
rutin
murin
coronaviru
dengu
viru
denv
method
antivir
activ
variou
concentr
ea
fraction
h
cordata
flavonoid
assess
use
viru
neutral
test
mous
hepat
viru
mhv
denv
type
cinanserin
hydrochlorid
also
test
mhv
ea
fraction
h
cordata
test
acut
oral
toxic
mice
result
ea
fraction
h
cordata
inhibit
viral
infect
cinanserin
hydrochlorid
abl
inhibit
mhv
inhibitori
concentr
ic
ea
fraction
h
cordata
ad
viral
adsorpt
stage
mgml
mhv
mgml
absenc
cytotox
mice
fed
ea
fraction
mgkg
induc
sign
acut
toxic
normal
histolog
featur
major
organ
certain
flavonoid
exhibit
compar
weaker
antivir
activ
notabl
quercetin
could
inhibit
mhv
follow
quercitrin
could
inhibit
mhv
wherea
rutin
exert
inhibitori
effect
either
viru
quercetin
combin
quercitrin
enhanc
activ
reduc
cytotox
observ
howev
synergist
efficaci
flavonoid
combin
still
less
ea
fraction
conclus
compound
h
cordata
contribut
superior
antivir
efficaci
ea
fraction
lack
cytotox
vitro
acut
toxic
vivo
h
cordata
much
potenti
develop
antivir
agent
coronaviru
dengu
infect
sever
acut
distress
syndrom
sar
highli
contagi
respiratori
ill
caus
sar
coronaviru
emerg
rapidli
spread
throughout
world
mortal
rate
although
diseas
disappear
reemerg
exclud
sinc
sarslik
coronavirus
zoonot
exist
anim
reservoir
eg
bat
raccoon
dog
palm
civet
thu
pose
potenti
risk
futur
epidem
sar
coronaviru
larg
envelop
singlestrand
positivesens
rna
viru
viral
genom
kbp
contain
open
read
frame
encod
polymeras
requir
viral
rna
synthesi
remain
open
read
frame
encod
structur
protein
ie
spike
envelop
membran
nucleocapsid
accessori
protein
first
identifi
emerg
middl
east
respiratori
syndrom
mer
coronaviru
caus
sever
pneumonia
multiorgan
involv
includ
acut
renal
failur
mortal
rate
death
case
document
june
consid
zoonot
viru
transmit
camel
middl
east
current
specif
treatment
exist
mer
coronaviru
murin
coronaviru
mous
hepat
viru
mhv
coronaviru
caus
epidem
murin
ill
high
mortal
gener
mhv
extrem
infecti
coloni
mice
caus
hepat
upon
infect
sar
mer
mhv
belong
group
coronavirus
classifi
genu
betacoronaviru
view
related
coronavirus
mhv
select
studi
act
surrog
model
sar
mer
coronavirus
necessit
facil
wherea
mhv
consid
pathogen
belong
genu
flaviviru
dengu
viru
denv
repres
import
mosquitoborn
viral
diseas
consider
resurg
mani
part
world
four
antigenicallyrel
distinct
denv
serotyp
infect
one
serotyp
confer
lifelong
immun
serotyp
denv
infect
caus
dengu
fever
occasion
seriou
condit
dengu
hemorrhag
fever
dengu
shock
syndrom
antibodydepend
enhanc
thought
play
central
role
dengu
pathogenesi
risk
develop
dengu
hemorrhag
fever
andor
dengu
shock
syndrom
greater
secondari
infect
compar
serotyp
differ
manifest
dengu
may
also
attribut
denv
variant
vari
degre
virul
viral
load
also
contribut
factor
develop
potenti
fatal
complic
addit
highli
preval
serotyp
tropic
subtrop
region
worldwid
select
studi
although
sever
dengu
candid
vaccin
undergo
clinic
trial
current
effect
antivir
therapi
urgent
need
control
dengu
belong
saururacea
famili
houttuynia
cordata
h
cordata
thunb
perenni
plant
nativ
mountain
region
eastern
asia
indefinit
spread
creep
rhizom
moist
locat
herb
possess
promis
antivir
properti
especi
clinic
import
envelop
virus
herp
simplex
influenza
viru
human
immunodefici
vitro
interestingli
steam
distil
h
cordata
strikingli
inactiv
envelop
viru
incap
inactiv
nonenvelop
viru
support
observ
other
demonstr
ethyl
acet
ea
fraction
h
cordata
effect
inhibit
infect
envelop
virus
denv
meng
et
al
discov
common
peak
hplcdad
ms
fingerprint
fresh
h
cordata
previou
project
verifi
peak
ea
extract
polyphenol
flavonoid
chlorogen
acid
hyperosid
quercetin
quercetrin
investig
antivir
efficaci
denv
flavonoid
class
natur
product
high
pharmacolog
potenc
ubiquit
photosynthes
cell
henc
like
consum
daili
flavonoid
known
display
antivir
activ
eg
glabranin
dengu
viru
procyanidin
pelargonidin
hsv
catechin
influenza
viru
use
virusspecif
neutral
test
studi
test
ea
fraction
h
cordata
antivir
efficaci
mhv
first
time
verif
use
differ
batch
h
cordata
specimen
three
flavonoid
compon
h
cordata
ie
quercetin
quercitrin
rutin
also
investig
antivir
activ
virus
also
select
sinc
common
natur
occur
flavonoid
whose
molecular
structur
share
high
degre
similar
mhv
experi
also
compar
potenc
cinanserin
hydrochlorid
proven
neutral
sar
coronaviru
vitro
compound
also
test
cytotox
vitro
ea
fraction
also
test
acut
oral
toxic
mice
plant
materi
ethanol
extract
aqueousea
fraction
flavonoid
h
cordata
aerial
part
fresh
leav
h
cordata
collect
farm
johor
malaysia
authent
depart
pharmacolog
nation
univers
singapor
voucher
specimen
h
cordata
deposit
singapor
botan
garden
assign
identif
number
prior
extract
herb
dri
weight
g
wash
deioniz
water
homogen
fine
powder
soak
overnight
vv
ethanol
next
day
ethanol
extract
remov
store
solvent
ad
blend
herb
left
soak
till
exhaust
extract
filter
concentr
rotari
evapor
buchi
rotavapor
freezedri
yield
g
crude
extract
powder
form
crude
extract
dissolv
ea
deioniz
water
water
ea
phase
separ
separ
funnel
ea
phase
concentr
rotari
evapor
concentr
ea
fraction
subsequ
store
c
overnight
freezedri
flavonoid
test
quercetin
dihydr
hplc
quercitrin
rutin
hydrat
purchas
sigmaaldrich
normal
mu
musculu
mous
liver
epitheli
cell
line
use
propag
mhv
mhv
neutral
test
compound
test
mhv
ea
fraction
h
cordata
flavonoid
compon
cinanserin
hydrochlorid
tocri
bioscienc
compound
serial
dilut
correspond
diluent
dilut
ad
well
microtit
plate
next
tcid
mhv
ad
dilut
compound
incub
c
h
co
also
test
treatment
diluent
variou
concentr
virusinfect
control
uninfect
cell
control
includ
batch
assay
confluent
cell
cultur
dmem
supplement
hors
serum
cell
seed
well
anoth
microtit
plate
incub
c
co
cell
confluent
cell
cultur
fluid
well
discard
viruscompound
mixtur
control
transfer
well
duplic
follow
addit
dmem
vv
hors
serum
plate
seal
incub
c
co
observ
daili
highest
dilut
compound
inhibit
cytopath
effect
cpe
consid
minimum
inhibitori
concentr
mic
new
guinea
c
strain
propag
aed
albopictu
mosquito
cell
line
maintain
leibovitz
medium
supplement
vv
fetal
bovin
serum
c
co
atmospher
activ
h
cordata
flavonoid
evalu
plaqu
reduct
neutral
test
prnt
babi
hamster
kidney
fibroblast
cultur
form
cell
monolay
plate
supplement
vv
fetal
bovin
serum
c
co
test
compound
dissolv
relev
diluent
serial
dilut
prepar
obtain
differ
concentr
new
guinea
c
neutral
monoclon
antibodi
chemicon
serv
posit
control
diluent
variou
concentr
viru
cell
control
also
includ
ad
correspond
diluent
viru
suspens
medium
without
treatment
compound
experi
perform
duplic
plaqueform
unit
pfu
incub
h
variou
concentr
compound
togeth
control
ad
cell
virussampl
mixtur
incub
cell
c
co
anoth
hour
rock
interv
cell
overlaid
carboxymethylcellulos
c
co
cell
fix
formaldehyd
stain
crystal
violet
number
plaqu
count
percentag
plaqu
reduct
compound
everi
dilut
determin
follow
mean
number
plaqu
viru
control
averag
number
plaqu
sampl
divid
mean
number
plaqu
viru
control
percentag
plaqu
reduct
plot
variou
concentr
test
agent
determin
concentr
caus
plaqu
reduct
ic
mtt
cell
prolifer
assay
perform
determin
cell
viabil
follow
exposur
test
compound
variou
concentr
test
compound
ad
well
contain
cell
monolay
incub
c
co
h
incub
mtt
reagent
ad
well
incub
h
purpl
precipit
visibl
invert
microscop
ml
gl
sd
moll
hcl
ad
well
incub
overnight
dark
room
temperatur
optic
densiti
od
nm
read
cell
inhibit
rate
calcul
formula
inhibit
rate
plot
variou
sampl
concentr
ascertain
concentr
caus
cytotox
cc
ea
fraction
flavonoid
either
individu
combin
test
concentr
neutral
test
assay
includ
well
contain
medium
well
untreat
control
cell
experi
repeat
mean
standard
deviat
calcul
approach
adapt
oecd
guidelin
test
chemic
acut
oral
toxic
fix
dose
procedur
reli
observ
clear
sign
toxic
even
mortal
nullipar
nonpregn
femal
mice
old
obtain
laboratori
anim
center
nation
univers
singapor
upon
arriv
kept
cage
prior
commenc
studi
actual
dosefeed
day
mice
fast
h
dose
mgkg
prepar
administr
use
water
vehicl
suspend
ethanol
extract
h
cordata
constant
volum
g
bodi
weight
total
five
group
mice
n
fed
singl
dose
extract
includ
vehicl
control
oral
gavag
sight
studi
conduct
frequent
first
min
special
attent
first
h
thereaft
condit
mous
observ
daili
detect
abnorm
chang
physic
appear
behavior
sign
bodi
weight
mice
final
euthan
observ
major
organ
brain
heart
lung
liver
kidney
harvest
histopatholog
examin
stain
hematoxylin
eosin
h
e
ea
fraction
h
cordata
evalu
concentr
mgml
mgml
tabl
figur
show
ea
fraction
h
cordata
exhibit
antimhv
activ
mic
mgml
without
appar
cytotox
effect
cell
test
concentr
mgml
antimhv
effect
quercetin
significantli
less
mic
mgml
figur
cytotox
cc
valu
mgml
select
index
howev
quercitrin
rutin
exhibit
antivir
activ
day
postinfect
dpi
concentr
mgml
tabl
cinanserin
hydrochlorid
test
concentr
rang
mgml
tabl
indic
cinanserin
exert
antimhv
activ
mic
mgml
dpi
mgml
dpi
figur
minim
cytotox
howev
dpi
viral
inhibit
observ
ea
fraction
h
cordata
test
start
highest
concentr
mgml
follow
dilut
mgml
mean
prnt
distinct
trend
inhibit
observ
variou
concentr
ea
fraction
without
cytotox
bhk
cell
ic
mgml
efficaci
ea
fraction
inhibit
infect
clearli
evid
concentr
mgml
complet
viral
inhibit
achiev
figur
individu
flavonoid
test
concentr
mgml
mgml
tabl
tabl
ea
fraction
quercetrin
rutin
dissolv
dmso
quercetin
dissolv
aqueou
alkali
moll
naoh
solubl
dmso
variou
concentr
ea
fraction
compound
subject
correspond
viral
neutral
test
well
mtt
assay
neg
control
dmso
aqueou
alkali
also
test
separ
prnt
mhv
neutral
test
mtt
assay
reveal
absenc
nonspecif
mhv
inhibit
well
lack
cytotox
solvent
data
shown
throughout
period
observ
control
group
well
four
group
mice
fed
vari
dose
h
cordata
extract
show
mortal
signific
weight
loss
data
shown
moreov
mice
appear
activ
wellgroom
euthanasia
histopatholog
section
major
organ
stain
h
e
signific
differ
control
group
test
group
exemplifi
figur
depict
control
group
compar
group
fed
highest
dose
mgkg
experiment
strategi
studi
investig
prophylact
antivir
effect
sinc
compound
allow
interact
virus
h
introduct
cell
approach
employ
previous
found
therapeut
effect
compound
ad
prior
infect
cell
denv
overal
studi
demonstr
ea
fraction
h
cordata
flavonoid
compon
quercetin
could
inhibit
mhv
vitro
follow
quercitrin
could
inhibit
mhv
wherea
rutin
exert
inhibitori
effect
virus
other
provid
evid
show
differ
flavonoid
compon
ea
fraction
h
cordata
exert
vari
degre
antivir
activ
differ
virus
find
corrobor
previou
evid
among
flavonoid
compon
quercetin
effect
wleklik
et
al
emphas
structur
basi
distinct
differ
antivir
activ
flavonoid
henc
noteworthi
bioactiv
quercetin
possess
hydroxyl
group
posit
compar
two
flavonoid
test
ie
rhamnos
quercitrin
rubinos
rutin
quercetin
aglycon
present
high
concentr
onion
compound
virucid
activ
envelop
virus
mengoviru
herp
simplex
parainfluenza
type
pseudorabi
respiratori
syncyti
sindbi
virus
quercetin
abl
inhibit
h
atpas
lysosom
membran
thu
prevent
viru
coat
remov
moreov
quercetin
exhibit
signific
inhibitori
effect
atpas
multidrug
resistanceassoci
protein
thu
increas
bioavail
anticanc
antivir
drug
vivo
henc
quercetin
consid
potenti
efficaci
antivir
drug
therapi
quercitrin
rutin
occur
glycosid
quercitrin
appear
show
highest
content
fingerprint
analysi
h
cordata
hplc
among
flavonoid
quercetin
also
exert
highest
activ
whilst
rutin
effect
characterist
impli
substitut
addit
free
hydroxyl
group
certain
posit
may
culmin
decreas
even
complet
abolish
antivir
effect
ea
fraction
h
cordata
test
concentr
mg
ml
mgml
upper
plot
reveal
distinct
trend
inhibit
ic
mgml
complet
viral
inhibit
achiev
concentr
mgml
lower
plot
show
cytotox
cell
evid
variou
concentr
ea
fraction
test
structuralact
relationship
lead
design
develop
activ
less
toxic
flavonoid
appropri
pharmacokinet
properti
henc
may
pave
way
novel
compound
match
even
exceed
efficaci
exist
antivir
drug
anoth
interest
aspect
enhanc
activ
quercetin
combin
quercitrin
besid
augment
antivir
effect
combin
also
reduc
cytotox
rel
induc
quercetin
alon
characterist
reiter
combin
compon
greater
antidengu
efficaci
lower
toxic
potenti
promis
discov
previous
use
combin
quercetin
chlorogen
acid
andor
hyperosid
inde
sever
report
alreadi
document
synergist
antivir
effect
combin
individu
flavonoid
viral
pathogen
herpesvirus
fowlpox
viru
although
cinanserin
abl
inhibit
mhv
mg
ml
dpi
mgml
dpi
effect
rel
shortliv
could
inhibit
mhv
dpi
onward
comparison
howev
observ
ea
fraction
quercetin
yield
longerlast
antivir
effect
find
may
explain
superimposit
two
proteinas
mhv
sar
cov
illustr
certain
amino
acid
residu
resid
within
activ
site
differ
shown
thu
amino
acid
dispar
may
influenc
recognit
bind
cinanserin
hydrochlorid
activ
site
may
also
lead
lower
affin
proteinas
mhv
sarscoronaviru
competit
bind
cinanserin
hydrochlorid
activ
site
proteinas
hinder
process
precursor
polyprotein
gener
function
replicas
necessari
viral
replic
importantli
ea
fraction
h
cordata
capabl
inhibit
mhv
vitro
rel
low
concentr
neglig
cytotox
good
select
indic
moreov
ea
fraction
also
potent
individu
compound
test
includ
combin
caus
cytotox
mammalian
kidney
bhk
liver
cell
line
vitro
acut
toxic
patholog
major
murin
organ
vivo
featur
reiter
synergist
effect
combin
multipl
flavonoid
constitu
within
h
cordata
confer
optim
antivir
activ
minim
toxic
keep
major
success
tradit
chines
medicin
studi
lend
support
accumul
literatur
ea
fraction
h
cordata
inde
repres
highli
promis
prophylact
agent
coronavirus
dengu
virus
complement
studi
futur
vivo
studi
warrant
assess
efficaci
ea
fraction
h
cordata
coronavirus
dengu
virus
use
relev
mous
model
howev
vivo
experi
necessari
assess
longterm
safeti
h
cordata
antivir
agent
biolog
system
includ
acquir
crucial
inform
adsorpt
distribut
metabol
elimin
address
import
issu
batchtobatch
variat
greater
effort
also
focu
qualiti
control
extract
deriv
medicin
plant
final
mechan
action
ea
fraction
constitu
flavonoid
virus
molecular
level
need
elucid
